Vaccines, Blood & Biologics
-
Anticoagulant Sodium Citrate 4% w/v Solution, USP
Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.
Manufacturer: Haemonetics Corporation, Braintree, MA
Indication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures
Approval Date: 3/3/2000
Type of submission: New Drug Application
-
Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Approval Letter Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Approval Letter (PDF - 71KB)Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Summary Basis of Approval Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Summary Basis of Approval (PDF - 119KB)
-
-
-
